Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sai Life SciencesNSE:SAILIFE +2.51%18 PS Ratio is 12.61 as of Jul. 17, 2026, which is 40% above its 10-year median of 9.02. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 200 Medical Diagnostics & Research companies, Sai Life Sciences ranks worse than 87.5% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sai Life Sciences's share price is ₹1294.90.
Sai Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹102.68. Hence, Sai Life Sciences's PS Ratio for today is 12.61.
Warning Sign:
Sai Life Sciences Ltd stock PS Ratio (=12.24) is close to 2-year high of 12.32.
The historical rank and industry rank for Sai Life Sciences's PS Ratio or its related term are showing as below:
NSE:SAILIFE'
s PS Ratio Range Over the Past 10 Years
Min: 7.82 Med: 9.02 Max: 12.61
Current: 12.61
During the past 5 years, Sai Life Sciences's highest PS Ratio was 12.61. The lowest was 7.82. And the median was 9.02.
NSE:SAILIFE's PS Ratio is ranked worse than 87.5% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.75
vs NSE:SAILIFE: 12.61
During the past 5 years, Sai Life Sciences's highest 3-Year average Revenue per Share Growth Rate was 27.10% per year. The lowest was 21.50% per year. And the median was 24.30% per year.
Back to Basics: PS Ratio
Sai Life Sciences (NSE:SAILIFE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sai Life Sciences PS Ratio Related Terms
Sai Life Sciences PS Ratio Historical Data
* Premium members only.
The historical data trend for Sai Life Sciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SAILIFE vs TMO, DHR, IDXX: PS Ratio Comparison
For the Diagnostics & Research subindustry, Sai Life Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Life Sciences PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sai Life Sciences's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sai Life Sciences's Share Price of today is ₹1294.90. Sai Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹102.68.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sai Life Sciences (NSE:SAILIFE) has a PS Ratio of 12.61 as of Jul. 17, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sai Life Sciences and its competitors. This is 40% above median its historical median of 9.02. Over the past decade, Sai Life Sciences' PS Ratio has ranged from 7.82 to 12.61. According to the industry distribution chart, Sai Life Sciences ranks #175 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 87.5%.
Is Sai Life Sciences' PS Ratio too high?
Sai Life Sciences' current PS Ratio of 12.61 is 40% above median its 10-year median of 9.02. Over the past 10 years, this metric has ranged from a low of 7.82 to a high of 12.61. The Medical Diagnostics & Research industry median PS Ratio is 2.75. Sai Life Sciences' value of 12.61 is 358.5% above this industry median. Based on the distribution chart, Sai Life Sciences ranks #175 out of 200 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #175 out of 200 companies for PS Ratio. This places Sai Life Sciences in the lower half of its industry. The industry median PS Ratio is 2.75. Sai Life Sciences' value of 12.61 is 358.5% above this benchmark. Historically, Sai Life Sciences' own PS Ratio has ranged from 7.82 to 12.61 over the past decade. While the company's 10-year median is 9.02 vs. the industry median of 2.75, Sai Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.75, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sai Life Sciences's current PS Ratio of 12.61 is 358.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sai Life Sciences and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sai Life Sciences's current PS Ratio is 12.61, which is 40% above median its own 10-year median of 9.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current PS Ratio of 12.61. The current PS Ratio is 12.61, which is 40% above median its 10-year median of 9.02 and 358.5% above the Medical Diagnostics & Research industry median of 2.75. Sai Life Sciences' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current PS Ratio is 12.61 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score
Get the complete analysis for NSE:SAILIFE
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAILIFE has been successfully added to your 
